Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Technology Scientific & Technical Instruments
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok... see more

Recent & Breaking News (TSXV:ARCH)

Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of Metablok

Canada NewsWire August 14, 2018

Arch Biopartners Receives $332,750 From the Exercise of Warrants

GlobeNewswire June 26, 2018

Arch Biopartners to Seek Regulatory Guidance From the U.S FDA for AB569

GlobeNewswire June 19, 2018

Arch Biopartners Announces Listing on OTCQB Exchange

GlobeNewswire May 16, 2018

Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients

GlobeNewswire May 8, 2018

Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance

GlobeNewswire March 27, 2018

Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury

GlobeNewswire March 21, 2018

Arch Biopartners Closes $1.25M Non-Brokered Private Placement Financing

GlobeNewswire March 9, 2018

Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio

GlobeNewswire February 27, 2018

Arch Biopartners Closes Convertible Note Financing

GlobeNewswire February 16, 2018

Arch Biopartners Arranges Convertible Note Financing

GlobeNewswire February 8, 2018

Arch Biopartners Announces Non Brokered Private Placement Financing

GlobeNewswire January 26, 2018

Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial

GlobeNewswire December 6, 2017

Arch Biopartners Engages Nucro Technics to Begin Toxicology Studies for Metablok

GlobeNewswire November 1, 2017

Arch Biopartners Closes Convertible Note Financing

Marketwired October 24, 2017

Arch Biopartners Initiates Manufacturing Process for Metablok

MarketWire Canada October 10, 2017

Arch Biopartners' GMP Manufacturing of AB569 Progresses to Final Production Stage

MarketWire Canada September 28, 2017

Arch Biopartners Increases Non-Brokered Private Placement Financing

MarketWire Canada September 12, 2017

Arch Biopartners Provides Update on GMP Manufacturing of AB569

MarketWire Canada July 27, 2017

Arch Biopartners Retains Market Maker and Arranges Non Brokered Private Placement Financing

Marketwired July 24, 2017